Get started
Author

Edmund Y. M. Chung

Observed names: E Chung, E.Y.M Chung, Edmund Chung, Edmund Y M Chung, Edmund Y. Chung, Edmund Y.M. Chung, Edmund YM Chung, Edmund Yin Man Chung, Edmund Y.M. Chung
Observed institutions: The University of Sydney, Royal North Shore Hospital, Wollongong Hospital, Children's Hospital at Westmead, Manly Hospital, Westmead Hospital, UNSW Sydney, Prince of Wales Hospital, Prince of Wales Hospital, Northern Sydney Local Health District, Sydney Children's Hospital
ORCID: 0000-0002-6897-2231
Observed ORCID: 0000-0002-6897-2231
OpenAlex ID: A5018544276
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
2020 · Edmund YM Chung, Marinella Ruospo, et al. · Cochrane Database of Systematic Reviews · 177
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
2021 · Edmund Y.M. Chung, Suetonia C. Palmer, et al. · American Journal of Kidney Diseases · 169
PDF
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
2023 · Edmund YM Chung, Suetonia C Palmer, et al. · Cochrane Database of Systematic Reviews · 64
PDF
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
2022 · Edmund Y. M. Chung, Katie Trinh, et al. · Frontiers in Cardiovascular Medicine · 56
PDF
The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
2021 · Zhubin Lun, Liwei Liu, et al. · Journal of Nephrology · 51
PDF
Interventions for preventing bone disease in kidney transplant recipients
2019 · Suetonia C Palmer, Edmund YM Chung, et al. · Cochrane Database of Systematic Reviews · 45
Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis
2025 · Nida Saleem, Jiayue Wang, et al. · JAMA Oncology · 41
Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?
2022 · Edmund Y. M. Chung, Sunil V. Badve, et al. · Nephrology · 36
PDF
Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment
2022 · Edmund Y. M. Chung, Yuan M. Wang, et al. · Frontiers in Immunology · 36
PDF
Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis
2022 · Bhadran Bose, Edmund Y. M. Chung, et al. · Journal of Nephrology · 27
PDF
Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials
2019 · Edmund Y.M. Chung, Suetonia C. Palmer, et al. · Transplantation · 25
Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor
2022 · Yuan Min Wang, Karli Shaw, et al. · Journal of the American Society of Nephrology · 17
Aldosterone Antagonists in Addition to Renin Angiotensin System Antagonists for Preventing the Progression of CKD: Editorial Summary of a Cochrane Review
2021 · Edmund Y.M. Chung, Giovanni F.M. Strippoli · American Journal of Kidney Diseases · 11
Predictive Models for Recurrent Membranous Nephropathy After Kidney Transplantation
2022 · Edmund Y. M. Chung, Katrina Blazek, et al. · Transplantation Direct · 8
Factors associated with functional arteriovenous fistula at hemodialysis start and arteriovenous fistula non-use in a single-center cohort
2021 · Edmund YM Chung, Debbie Knagge, et al. · The Journal of Vascular Access · 8
A Case Report of Henoch–Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban
2018 · Edmund YM Chung, Jason Chen, et al. · Nephrology · 8
T cell costimulatory blockade ameliorates induction of experimental membranous nephropathy potentially through T-helper 17 cell suppression in the kidney
2025 · Edmund Y M Chung, Yuan Min Wang, et al. · Nephrology Dialysis Transplantation · 6
Correction to: The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
2021 · Zhubin Lun, Liwei Liu, et al. · Journal of Nephrology · 5
PDF
Retrospective study on the epidemiology of antineutrophil cytoplasmic autoantibodies‐associated vasculitis in two Australian health districts
2020 · Edmund Y. M. Chung, Dante Risi, et al. · Internal Medicine Journal · 5
Glomerular, Mesangial, and Tubular Cytoplasmic Fibrillary Inclusions in a Patient with Light-Chain Proximal Tubulopathy
2020 · Edmund Y.M. Chung, Kirsten McIlroy, et al. · The Nephron journals/Nephron journals · 3
Pharmacological interventions in IgA nephropathy: protocol for a living systematic review and network meta-analysis
2025 · Soumita Bagchi, Armando Teixeira-Pinto, et al. · BMJ Open · 2
Patients’ Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study
2025 · Edmund Y.M. Chung, Simon A. Carter, et al. · American Journal of Kidney Diseases · 2
CD8 + Regulatory T Cells Induced by Peptide Vaccination Ameliorates Experimental Model of Membranous Nephropathy
2025 · Edmund Y. M. Chung, Yuan Min Wang, et al. · Nephrology · 2
PDF
Hybrid dialysis: Two modalities twice the benefit?
2025 · Edmund YM Chung, Kamal Sud · Peritoneal Dialysis International · 1
Global risk factors of contrast-induced acute kidney injury: systematic review and meta-analysis
2020 · L Liu, Y Liu, et al. · European Heart Journal · 1
Works count: 40
Citation count: 808
H-index: 12
I10-index: 13
Year
Topic
Type